"
Neoadjuvant Therapy for Resectable and Borderline Resectable Pancreatic Cancer"
written by Susan Tsai, Kathleen K. Christians, Ben George, Paul Ritch, Kiyoko Oshima, Parag Tolat, Ashley Krepline, Beth A. Erickson, Douglas B. Evans,
published by
Journal of Cancer Therapy,
Vol.7 No.1, 2016
has been cited by the following article(s):
|
[1]
|
Intraoperative Radiation “Boost” to the Surgical Resection Bed following Pancreaticoduodenectomy for a Borderline Resectable Pancreatic Carcinoma: A Case Report
Frontiers in Oncology,
2018
DOI:10.3389/fonc.2018.00012
|
|
|
|
|
[2]
|
Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs
Journal of Gastrointestinal Surgery,
2017
DOI:10.1007/s11605-017-3470-6
|
|
|
|
|
[3]
|
Diagnostic Laparoscopy Prior to Neoadjuvant Therapy in Pancreatic Cancer Is High Yield: an Analysis of Outcomes and Costs
Journal of Gastrointestinal Surgery,
2017
DOI:10.1007/s11605-017-3470-6
|
|
|
|